Lisinopril only and a combination of lisinopril and losartan for IgA nephropathy with focal mesangial proliferation in children: A randomized controlled trial of efficacy and safety

The requested reference [07725c1feb5b1c52657faabc92b93a3e02fc0d49] no longer exists in our database. It has been replaced by the current reference: [6afaaeb805a0e7e0fd77b2070dc8bf22f379f400]

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2005
INTERVENTION: Lisinopril for 2 years Lisinopril+losartan for 2 years CONDITION: IgA nephropathy in children PRIMARY OUTCOME: Disappearance rate of proteinuria INCLUSION CRITERIA: 1.Biopsy diagnoses of IgA nephropathy with focal mesangial proliferation, where a renal biopsy has been performed within 4 months before eligibility. 2.Proteinuria with a urinary protein‐creatinine ratio >0.2. 4.Aged 2 to 18 years. 5.Written informed consent from the patients' parents or legal guardians.
Epistemonikos ID: 1e8c64eb84759698d165bf4c6ee709c3ab34ad86
First added on: Aug 21, 2024